Hypertensive Disorders of Pregnancy
Conditions
Interventions
Experimental Group (Checklist Follow-up Group):List-based postpartum follow-up
Control group:At present, regular postpartum follow-up is conducted
Observation group (Qualitative study):None
Sponsors
The Third Affiliated Hospital of Guangzhou Medical University
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Inclusion criteria for qualitative research: (1) Pregnant women with gestational hypertension who meet the diagnostic criteria of the Guidelines for the Diagnosis and Treatment of gestational hypertension disorders of the Obstetrics and Gynecology Branch of the Chinese Medical Association (including gestational hypertension, preeclampsia - eclampsia, pregnancy complicated with chronic hypertension, and chronic hypertension with preeclampsia), and whose postpartum time is =18 years old, clear consciousness, and normal language expression ability; (4) The condition permits and the patient is willing to be interviewed. (5) Voluntarily participate in this study and sign the informed consent form. 2.Inclusion criteria for non-randomized controlled trials: (1) Pregnant women with gestational hypertension disorders who meet the diagnostic criteria of the "Diagnosis and Treatment Guidelines for Gestational Hypertension Disorders (2020)" of the Obstetrics and Gynecology Branch of the Chinese Medical Association (including gestational hypertension, preeclampsia - eclampsia, pregnancy complicated with chronic hypertension, and chronic hypertension with preeclampsia); (2) Age >=18 years old, clear consciousness, and normal language expression ability; (3) Voluntarily participate in this study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1.Exclusion criteria for qualitative studies: (1) Severe dysfunction of organs such as the heart, liver, and kidneys (such as heart failure, chronic renal failure); (2) Combined with mental illness or cognitive impairment; (3) Severe complications after childbirth (such as postpartum hemorrhage and pulmonary embolism) require re-hospitalization for treatment. (4) Due to personal reasons, it is impossible to ensure the completion of the interview, or clearly indicate the refusal of participants. 2.Exclusion criteria for non-randomized controlled trials: (1) Complicated with severe dysfunction of heart, liver, kidney and other organs (such as heart failure, chronic renal failure); (2) Complicated with mental illness or cognitive impairment; (3) Severe complications after delivery (such as postpartum hemorrhage, pulmonary embolism) requiring re-hospitalization; (4) Unable to ensure completion of follow-up due to personal reasons, or explicitly refusing to participate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The average blood pressure value 42 days postpartum;Blood pressure control rate at 42 days postpartum; | — |
Secondary
| Measure | Time frame |
|---|---|
| WHOQOL-BREF score;Renal function indicators (serum creatinine, urine protein);Blood glucose and lipid indicators;Weight loss (difference between body weight at 42 days postpartum and before delivery);Compliance with blood pressure monitoring;Edinburgh Postnatal Depression Scale (EPDS) scores;State Anxiety Inventory (S-AI) score; | — |
Countries
China
Contacts
Public ContactTaizhen Luo
The Third Affiliated Hospital of Guangzhou Medical University
Outcome results
None listed